StockData
SciSparc Ltd. logo

SciSparc Ltd. (SPRC) stock

SPRCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026Score 3/30
$0.33−0.00 (-0.30%)

Close on Nov 17, 2026Market cap $120.49KP/E 0.0Yield –

SciSparc operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

For fiscal 2025 it was -$8.37M. The highest annual figure on record is $2.56M in fiscal 2015.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.37M–
FY2024Dec 31, 2024-$7.32M–
FY2023Dec 31, 2023-$6.82M–
FY2022Dec 31, 2022-$8.29M–
FY2021Dec 31, 2021-$5.77M–
FY2020Dec 31, 2020-$3.29M–
FY2019Dec 31, 2019-$4.11M–
FY2018Dec 31, 2018-$7.24M–
FY2017Dec 31, 2017-$5.75M–
FY2016Dec 31, 2016-$2.00M-178.0%
FY2015Dec 31, 2015$2.56M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2018Jun 30, 2018-$1.65M–
Q2 FY2017Jun 30, 2017-$1.43M–

More SciSparc figures

See a number that looks wrong?